Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Qualys, Inc. - Common Stock (NQ:QLYS)

120.62 -0.73 (-0.60%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Qualys, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Analyst Ratings for Qualys
Via Benzinga
Cloud Stocks: Analysis Of Qualys’s Blue Hexagon Acquisition
Recently, Qualys announced the acquisition of the assets of AI/ML-based cloud threat detection and response solutions provider Blue Hexagon for an undisclosed sum. 
Via Talk Markets
Qualys's Return On Capital Employed Overview
Via Benzinga
Stock Market Rally Tumbles On Hawkish Fed Chief Powell; Jobs, Earnings Also In Focus: Weekly Review
A mixed jobs report and heavy earnings swung stocks. 
Via Investor's Business Daily
Kellogg, Palo Alto Networks, Roku And Other Big Losers From Thursday
U.S. stocks closed lower on Thursday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  Friday's session saw 236 companies set new 52-week lows. 
Via Benzinga
Where Qualys Stands With Analysts
Within the last quarter, Qualys (NASDAQ:QLYS) has observed the following analyst ratings: 
Via Benzinga
Qualys' VMDR Platform Earns It Analyst Upgrade
Via Benzinga
Expert Ratings for Qualys
Qualys (NASDAQ:QLYS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Why Greenhill Shares Climbed Around 25%; Here Are 100 Biggest Movers From Yesterday
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) shares jumped 242.8% to close at $105.72 on Thursday. The company announced a strategic plan to enter into the clean energy industry. 
Via Benzinga
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60. 
Via Benzinga
Earnings Preview: Qualys
Qualys (NASDAQ:QLYS) is set to give its latest quarterly earnings report on Wednesday, 2022-11-02. Here's what investors need to know before the announcement. Analysts estimate that Qualys will report... 
Via Benzinga
The 7 Biggest Cybersecurity Stocks Ranked From Best to Worst
Investors can get ahead by differentiating among the cybersecurity stocks with the highest growth potential, and avoiding the worst. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For October 21, 2022
Upgrades 
Via Benzinga
Cybersecurity Palo Alto Networks Stock Flashing Renewed Technical Strength
On Thursday, Palo Alto Networks stock had its Relative Strength (RS) Rating upgraded to 83, up from 76 a day earlier. 
Via Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022
Upgrades 
Via Benzinga
Check Point Software Technologies Stock Trying To Close In On Key Technical Measure
The Relative Strength Rating for Check Point Software Technologies stock jumped into a new percentile Friday, as it got a lift from 67 to 71. 
Via Investor's Business Daily
7 Top Tech Stocks to Buy Heading Into Q4 2022
Tech stocks are down big in 2022, but that doesn't mean you shouldn't be looking for the top tech stocks to buy for the fourth quarter. 
Via InvestorPlace
Verint Systems Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
Verint Systems sees its Relative Strength Rating enter the 80-plus level. 
Via Investor's Business Daily
Palo Alto Networks Stock Earns Relative Strength Rating Upgrade
Palo Alto Networks stock reached a key technical milestone, with its Relative Strength Rating upgraded to 92, a rise from 87 the day before. 
Via Investor's Business Daily
Cloud Stocks: Qualys Leverages Partner Network To Drive Go-To-Market Agenda
Qualys continues to execute on its go-to-market agenda well by leveraging its evolving partner ecosystem. In May this year, the company launched a new partner program. 
Via Talk Markets
7 A-Rated Tech Stocks to Buy and Hold Now
These A-rated tech stocks are a reliable source of solid returns and can be great momentum play now that tech stocks are bouncing back. 
Via InvestorPlace
CyberArk Software Stock Sees Relative Strength Rating Climb To 77
In a welcome move, CyberArk Software stock saw its Relative Strength Rating rise from 64 to 77 on Wednesday. 
Via Investor's Business Daily
'Investor Anxiety' On Software Stocks Prevails, But This Analyst Sees Hope In A Few Stocks, With Questions Around Others -- Like Palantir
On average, software companies beat Q2 revenue estimates by 2% and profitability expectations by 5%, RBC analyst Matthew Hedberg said.  Q3 was guided lower for both revenue and profitability while... 
Via Benzinga
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
The major indexes continued to advance, despite some key warnings. 
Via Investor's Business Daily
Qualys Stock Climbs On Earnings Beat, Nears Buy Point
Qualys stock rose 12% on Tuesday in the wake of its earnings report. In Wednesday afternoon trading it was up another 3.6%. 
Via Investor's Business Daily
What 5 Analyst Ratings Have To Say About Qualys
  Over the past 3 months, 5 analysts have published their opinion on Qualys (NASDAQ:QLYS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
11 Information Technology Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.